More than 90% of ACE-accredited facilities feel that accreditation adds substantial value to their organization in terms of improved care quality. - Bonnie H. Weiner, MD, ACE Chief Medical Officer
Washington, DC (PRWEB) April 28, 2015
For the first time, cardiac catheterization laboratory stakeholders now have quality metrics that confirm the value of ACE accreditation. During the 2015 Society for Cardiovascular Angiography and Interventions (SCAI) Scientific Sessions in San Diego, CA, May 6-9, 2015, ACE will present findings from three new studies validating the diverse benefits of ACE accreditation.
In the series of studies, Bonnie H. Weiner, MD, MSEC, MBA, MSCAI, FACC, and colleagues examined multiple quality, performance, and outcome measures among 24 facilities that have achieved full ACE accreditation for their diagnostic cardiac catheterization and percutaneous coronary intervention (Cath/PCI) programs and 4 facilities that did not meet the rigorous standards for ACE accreditation.
“We found that ACE-accredited cardiac catheterization laboratories were significantly more likely than non-accredited facilities to meet the highest-quality standards for more than a dozen structural, process-related, and procedural domains,” said Dr. Weiner, ACE’s chief medical officer. “These data clarify and support the critical role of ACE accreditation in assisting facilities to provide excellent cardiovascular care.”
The studies focused on structural and process domains (Abstract 13849) and case-level procedural characteristics (Abstract 13862) that significantly differentiated ACE-accredited cardiac catheterization laboratories from facilities that did not achieve accreditation. Additional survey data highlighted the perceived value of undergoing the ACE external review and accreditation and process (Abstract 13833).
“More than 90% of ACE-accredited facilities feel that accreditation adds substantial value to their organization in terms of improved care quality,” Dr. Weiner said. “The value proposition of ACE accreditation touches every aspect of the cardiac catheterization laboratory, from enhanced patient safety to improved staff confidence and morale.”
Dr. Weiner will discuss findings from all three studies during a special ePoster Bar Q & A session on Thursday, May 7, 2015, beginning at 3:20 pm in the Exhibit Hall (Sapphire BCD) of the Hilton San Diego Bayfront. The study abstracts are viewable on the SCAI 2015 mobile app and in the May 2015 issue of Catheterization and Cardiovascular Interventions.
Be sure to follow our SCAI 2015 meeting coverage on Twitter (@ACE_CVEXCEL) and stop by the ACE exhibit (Booth 115) to get the latest information on quality sessions.
About Accreditation for Cardiovascular Excellence (ACE)
ACE is the global leader in accreditation and external quality review services for all catheter-based cardiovascular procedures. ACE, an independent organization sponsored by the Society for Cardiovascular Angiography and Interventions (SCAI) and the American College of Cardiology Foundation (ACCF), offers independent evaluation and monitoring of facilities that provide cardiovascular care. By reviewing facility and operator performance and comparing clinical decision-making to nationally accepted best practices, ACE quality review and accreditation services play a critical role in continuous quality improvement programs. Join us. Let us exceed your expectations and provide a free consultation. Contact ACE at info(at)cvexcel(dot)org or call our office at 202.657.6859 or visit our website at http://www.cvexcel.org.